Combivent Patient Info

Drug Library
Combivent - Patient Info [ipratropium bromide and albuterol sulfate]

7. Replace protective cap after use.

8. Keep the mouthpiece clean. Wash with hot water. If soap is used, rinse thoroughly with plain water. Dry thoroughly before use. When dry, replace cap on the mouthpiece when not using the drug product.

9. Track the number of sprays used and discard after 200 sprays. The amount of medication in each inhalation cannot be assured after 200 sprays.

10. While taking Combivent Inhalation Aerosol, other inhaled drugs should be taken only as directed by your physician.

11. If the recommended dosage does not provide relief or symptoms become worse, patients should seek immediate medical attention. Do not increase the dose or frequency of Combivent Inhalation Aerosol without consulting your physician.

12. Note: The indented statement below is required by the Federal government's Clean Air Act for all products containing or manufactured with chlorofluorocarbons (CFCs):

This product contains trichloromonofluoromethane (CFC-11), dichlorodifluoromethane (CFC12) and dichlorotetrafluoroethane (CFC-114), substances which harm the environment by destroying ozone
in the upper atmosphere.

Your physician has determined that this product is likely to help your personal health. USE THIS PRODUCT AS DIRECTED, UNLESS INSTRUCTED TO DO OTHERWISE BY YOUR PHYSICIAN. If you have any questions about alternatives, consult with your physician.

13. The contents of Combivent Inhalation Aerosol are under pressure. Do not puncture. Do not use or store near heat or open flame. Exposure to temperatures above 120° F may cause bursting. Never throw the container into a fire or incinerator. Keep out of reach of children. Avoid spraying in eyes.

Store between 59° F (15° C) and 86° F (30° C). Avoid exces-sive humidity. Manufactured by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA
Ipratropium bromide licensed from: Boehringer Ingelheim International GmbH

© Copyright Boehringer Ingelheim Pharmaceuticals, Inc. 2001, ALL RIGHTS RESERVED
Revised 9/ 01 10000291/ 03 10000291/ US/ 03